A detailed history of Deutsche Bank Ag\ transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 221,278 shares of ARWR stock, worth $4.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
221,278
Previous 225,405 1.83%
Holding current value
$4.34 Million
Previous $5.86 Million 26.89%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$19.36 - $29.54 $79,898 - $121,911
-4,127 Reduced 1.83%
221,278 $4.28 Million
Q2 2024

Aug 14, 2024

SELL
$21.87 - $28.24 $154,096 - $198,979
-7,046 Reduced 3.03%
225,405 $5.86 Million
Q1 2024

May 15, 2024

SELL
$27.21 - $39.48 $264,753 - $384,140
-9,730 Reduced 4.02%
232,451 $6.65 Million
Q4 2023

Feb 14, 2024

BUY
$21.2 - $31.03 $408,990 - $598,630
19,292 Added 8.66%
242,181 $7.41 Million
Q3 2023

Nov 09, 2023

BUY
$26.2 - $36.08 $142,685 - $196,491
5,446 Added 2.5%
222,889 $5.99 Million
Q2 2023

Aug 14, 2023

SELL
$25.16 - $41.38 $679,269 - $1.12 Million
-26,998 Reduced 11.04%
217,443 $7.75 Million
Q1 2023

May 15, 2023

BUY
$23.68 - $38.51 $420,343 - $683,591
17,751 Added 7.83%
244,441 $6.21 Million
Q4 2022

Feb 13, 2023

BUY
$28.0 - $40.56 $144,760 - $209,695
5,170 Added 2.33%
226,690 $9.19 Million
Q3 2022

Nov 14, 2022

SELL
$29.63 - $48.31 $3.35 Million - $5.45 Million
-112,902 Reduced 33.76%
221,520 $7.32 Million
Q2 2022

Aug 11, 2022

SELL
$27.79 - $50.61 $204,784 - $372,945
-7,369 Reduced 2.16%
334,422 $11.8 Million
Q1 2022

May 13, 2022

BUY
$39.62 - $69.97 $3.89 Million - $6.87 Million
98,142 Added 40.28%
341,791 $15.7 Million
Q4 2021

Feb 11, 2022

SELL
$58.09 - $82.51 $73,483 - $104,375
-1,265 Reduced 0.52%
243,649 $16.2 Million
Q3 2021

Nov 04, 2021

SELL
$58.38 - $84.96 $1.25 Million - $1.82 Million
-21,465 Reduced 8.06%
244,914 $15.3 Million
Q2 2021

Aug 11, 2021

SELL
$62.15 - $90.32 $10.1 Million - $14.7 Million
-163,254 Reduced 38.0%
266,379 $22.1 Million
Q1 2021

May 13, 2021

BUY
$61.35 - $90.47 $7.46 Million - $11 Million
121,527 Added 39.44%
429,633 $28.5 Million
Q4 2020

Feb 16, 2021

BUY
$43.82 - $85.37 $5.84 Million - $11.4 Million
133,332 Added 76.29%
308,106 $23.6 Million
Q3 2020

Nov 12, 2020

SELL
$33.21 - $51.27 $710,561 - $1.1 Million
-21,396 Reduced 10.91%
174,774 $7.53 Million
Q2 2020

Aug 13, 2020

BUY
$26.12 - $43.27 $3.19 Million - $5.28 Million
121,998 Added 164.48%
196,170 $8.47 Million
Q1 2020

May 14, 2020

SELL
$20.56 - $63.12 $6.54 Million - $20.1 Million
-318,002 Reduced 81.09%
74,172 $2.13 Million
Q4 2019

Feb 14, 2020

BUY
$28.14 - $73.01 $412,898 - $1.07 Million
14,673 Added 3.89%
392,174 $24.9 Million
Q3 2019

Nov 14, 2019

SELL
$26.26 - $34.86 $6.33 Million - $8.4 Million
-240,920 Reduced 38.96%
377,501 $10.6 Million
Q2 2019

Aug 14, 2019

BUY
$17.43 - $28.82 $7.01 Million - $11.6 Million
401,953 Added 185.69%
618,421 $16.4 Million
Q1 2019

May 15, 2019

BUY
$12.05 - $20.18 $2.13 Million - $3.56 Million
176,643 Added 443.55%
216,468 $3.97 Million
Q4 2018

Feb 14, 2019

SELL
$10.74 - $19.7 $3.98 Million - $7.3 Million
-370,774 Reduced 90.3%
39,825 $494,000
Q3 2018

Dec 21, 2021

BUY
$14.0 - $20.3 $3.17 Million - $4.6 Million
226,522 Added 123.06%
410,599 $7.87 Million
Q3 2018

Nov 14, 2018

SELL
$14.0 - $20.3 $603,274 - $874,747
-43,091 Reduced 18.97%
184,077 $3.53 Million
Q2 2018

Apr 21, 2020

BUY
$6.37 - $14.02 $273,738 - $602,481
42,973 Added 23.33%
227,168 $3.09 Million
Q2 2018

Aug 14, 2018

SELL
$6.37 - $14.02 $335,380 - $738,153
-52,650 Reduced 22.23%
184,195 $2.5 Million
Q1 2018

Oct 18, 2019

BUY
$3.72 - $7.64 $514,457 - $1.06 Million
138,295 Added 140.33%
236,845 $1.71 Million
Q1 2018

May 15, 2018

BUY
$3.72 - $7.64 $241,632 - $496,256
64,955 Added 193.35%
98,550 $710,000
Q4 2017

Feb 14, 2018

SELL
$3.14 - $4.5 $5,984 - $8,577
-1,906 Reduced 5.37%
33,595 $122,000
Q3 2017

Nov 14, 2017

BUY
$1.69 - $4.33 $59,996 - $153,719
35,501
35,501 $152,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.08B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.